About us
Who We Are
Learn about our mission, our charter and principles, and who we are.
Europe & Central Asia
Europe & Central Asia
Afghanistan
Decades of conflict have ruined Afghanistan’s economy and infrastructure and many people rely on humanitarian aid.
Europe & Central Asia
Albania
MSF first worked in Albania in 1998 and closed its projects in 2000.
Europe & Central Asia
Armenia
In Armenia, MSF first worked in the country in 1988 to respond to medical needs following the Spitak earthquake, before treating people with drug-resistant tuberculosis with new, effective drugs. We closed our last projects in 2019.
Europe & Central Asia
Azerbaijan
After working in Azerbaijan for more than ten years, MSF closed its last projects in 2003.
Europe & Central Asia
Belarus
We are working with the Ministry of Health in Belarus to improve adherence to treatment for patients with multidrug-resistant tuberculosis (MDR-TB).
Europe & Central Asia
Belgium
In Belgium, MSF teams work with migrants and refugees, and are working in nursing homes and with homeless people in response to the COVID-19 pandemic.
Europe & Central Asia
Bosnia and Herzegovina
After a decade working with populations affected by the Balkan wars, we ended our work in Bosnia and Herzegovina in 2001. In 2018, we returned to assist migrants and refugees escaping war and persecution in the Middle East, Asia and Africa.
21,700
outpatient consultations1,200
individual mental health consultations
Europe & Central Asia
Bulgaria
MSF first worked in Bulgaria in 1981 and closed its projects in 2015.
Europe & Central Asia
Croatia
MSF closed its projects in Croatia in 1998.
Europe & Central Asia
France
In Paris, northern France and at the borders with Italy and Spain, migrants and refugees encounter policies and practices aimed at preventing them from settling or claiming their rights.
Europe & Central Asia
Georgia
MSF began working in Georgia in 1993 to deliver healthcare to people affected by internal displacement and conflict, before providing treatment to people with multidrug-resistant tuberculosis (MDR-TB).
Europe & Central Asia